comparemela.com

Latest Breaking News On - Prostate screening episwitch - Page 1 : comparemela.com

Global Prostate-Specific Antigen (PSA) Testing Market to Reach $19 43 Billion by 2033, Driven by Rising Prostate Cancer Cases and Technological Advancements

/PRNewswire/ The "Prostate-Specific Antigen Testing Market, By Test, By Sample, By End User, and by Region - Global Forecast to 2023-2033" report has been.

United statesLaura woodRobertf smithAsia pacificHanzhou testseaBeckman coulter incLaboratory corporation of america holdingsOffice hours callHealth incUniversity of east angliaBio rad laboratories incFujirebiohu groupDrug administrationBayer agBoston scientific corporationCarroll petrie department of urology

Innovations in PSA Testing and Cancer Therapies Fuel Market

Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) The

United statesRobertf smithAsia pacificHanzhou testseaBeckman coulter incBayer agBoston scientific corporationUniversity of east angliaHealth incCarroll petrie department of urologyBio rad laboratories incFujirebiohu groupDrug administrationLaboratory corporation of america holdingsSpecific antigen testing marketEnd user

New blood test which can detect prostate cancer with 94% accuracy

A blood test that can help detect more than 90 per cent of prostate cancer cases is now available in Britain.

City ofUnited kingdomCharing crossMathias winklerImperial collegeImperial college londonUniversity of east angliaProstate screening episwitchOxford biodynamicsEast angliaCharing cross hospital

A game-changing prostate test can help detect more cancer cases

A new blood test for prostate cancer will help detect more cases and is set to be rolled out later this year.

Eastender shane richieNaomi elsterColin mcfarlaneImperial collegeProstate cancer researchUniversity of east angliaProstate screening episwitchEast angliaDark knightBlood testProstate cancer

Oxford Biodynamics first-half losses widen

Oxford BioDynamics reported revenue of £0.22m in its first half on Tuesday, up from £0.09m in the same period a year earlier.

United statesJon burrowsProstate screening episwitchOxford biodynamicsNational institutesHealth public private partnership awardsPrecompetitive translational researchFirst halfCategory allCategory market reportCategory company newsCategory news and announcementsCategory aim bulletinCategory tecnologiaCategory market pulseCategory sectorial health technology

vimarsana © 2020. All Rights Reserved.